Register / Log In

Pharmacy News

FDA approves once-weekly GLP-1 receptor agonist for type 2 diabetes
FDA has approved dulaglutide (Trulicity, Eli Lilly) to treat type 2 diabetes mellitus. The drug is a once-weekly subcutaneous injection used to improve glycemic control and is indicated as an adjunct to diet and exercise in the management of type 2 diabetes in adults.
Pharmacy in Blue Ridge: Two generations of small-town pharmacy
Two fathers and their sons keep the ideals of small-town pharmacy practice alive for 65 years.
Buprenorphine tops list for pediatric poisoning requiring hospitalization
Researchers from the Centers for Disease Control and Prevention (CDC) and FDA undertook a study to determine the most commonly implicated active ingredients responsible for childhood poisonings that required emergency hospitalization in the hope of identifying prevention and intervention strategies. Buprenorphine and clonidine were the most common of 12 active ingredients that were found in 45.0% of these hospitalizations.
Home infusion bill would benefit seriously ill Medicare patients
Proposed legislation that would cover home-based infusion therapy for Medicare beneficiaries could save the healthcare system approximately $80 million over 10 years and provide access to life-saving care at patients’ homes. The potential savings is outlined in a report released in June by Avalere.
BMJ Study: CV benefits of statin use far exceed risks
A literature review going back 20 years found only a modest increase in patients' risk of developing statin-related conditions.
Serving Mingo Junction
He's not filling a niche, he's serving a need, says pharmacist Frank Vostatek, who can add "role model" to the rest of his job description.
New once-weekly treatment for type 2 DM
Albiglutide injection is the newest GLP-1 approved for once-weekly dosing in patients with type II diabetes, to be used in addition to diet and exercise.
In the pharmacy: Heads up for autumn hair care
It's back-to-school season. Mom and Dad can be losing their hair for a few reasons — finding something crawling on the kids' heads is just the beginning. Here's a host of solutions for parents and their young.
Drug Topics Voices, September 2014
Letters, e-mails, posts, and tweets from the readers of Drug Topics magazine.
New products for pharmacists 09-10-2014
New Rx, indications, generics, and OTC
Stay Connected